Sfoglia per Rivista HAEMATOLOGICA
Pharmacokinetics of the reformulated B-DOMAIN deleted recombinant factor VIII (BDD-RFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS)
2007 Santoro, Cristina; Mazzucconi, Maria Gabriella; Pignoloni, F.; Rago, A.; Biondo, F.; Iorio, A.; Ferrante, F.; Agnelli, G.; Foa, R.
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
2024 Kaiser, Francesca; Lunghi, Monia; Cardinali, Deborah; Bellomarino, Vittorio; Beldinanzi, Marco; Starza, Irene Della; Malfona, Francesco; Basilico, Claudia M.; Defina, Marzia; Mastaglio, Sara; Giglio, Fabio; Lazzarotto, Davide; Salutari, Prassede; Piccini, Matteo; Cardinali, Valeria; Pierini, Antonio; Fracchiolla, Nicola S.; Di Biase, Federica; Annunziata, Mario; Di Trani, Mariangela; Foa, Robin; Chiaretti, Sabina
Preliminary data of a randomized pluricentric study (ABVD +RT EF versus IF) in intermediate stage Hodgkin’s disease (HD)
1998 Anselmo, Anna Paola; MAURIZI ENRICI, Riccardo; S., Proia; E., Cavalieri; B., Campanella; M., Cantonetti; G., Bellesi; G. P., Biti; Mandelli, Franco
PREOPERATIVE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ITP PATIENTS PRIOR TO SPLENECTOMY OR CARDIOVASCULAR SURGERY
2014 Rossi, E; Ciminello, A; Cedrone, M; Santoro, Cristina; Buccisano, F; De Padua, L; Za, T; Betti, S; Anaclerico, B; Mazzucconi, Maria Gabriella; De Stefano, V.
PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS
2010 Federici, A; Iorio, A.; Castaman, G.; Mazzucconi, Maria Gabriella; Morfini, M.; Rocino, A.; Schiavoni, M.; Mannucci, P.
PRIOR THROMBOSIS AND CLINICO-BIOLOGICAL CHARACTERISTICS AT DIAGNOSIS IN THE PATIENTS OF THE THROMBOCYTHEMIAS ITALIAN REGISTRY: IS OLDER AGE A PRIMARY OR A SURROGATE PROTHROMBOTIC FACTOR?
2014 Gugliotta, L; Iurlo, A; Tieghi, A; Gugliotta, G; Candoni, A; Ricco, A; Lunghi, M; Rumi, E; Scalzulli, Pr; Dragani, A; Antonioli, E; Martinelli, V; Randi, Ml; Maschio, N; Appolloni, V; Cantore, N; Palmieri, F; Santoro, Cristina; Polverelli, N; De Biasi, E; Rago, A; Cacciola, R; Villa, Mr; Codeluppi, K; Piccin, A; Pierri, I; Martino, B; Santoro, U; Monari, P; Miglio, R.
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myelogenous leukemia.
2004 Ricciardi, Maria Rosaria; Mcqueen, T; Chism, Dd; Milella, M; Kaldjian, E; Sebolt Leopold, J; Konopleva, M; Andreeff, M.
Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib.
2005 M., Breccia; Muscaritoli, Maurizio; Alimena, Giuliana
REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL
2017 Martini, V; Molfetta, R; Severin, F; Trimarco, V; Frezzato, F; Raggi, F; Martinello, L; Visentin, A; Scomazzon, E; Facco, M; Semenzato, G; Paolini, R; Trentin, L.
Response of prostate cancer during imatinib therapy in a patient with chronic myeloid leukemia.
2004 Breccia, M.; De Cuia, M. R.; D'Elia, G. M.; Biondo, F.; Mandelli, Franco; Alimena, Giuliana
RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF A-HYPO-FIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS
2017 Santoro, Cristina; Massaro, Fulvio; Baldacci, E; Ferrara, G; Ferretti, Antonietta; Santoro, Rc; Pasca, S; Castaman, G; Peyvandi, F; Foa, Roberto; Mazzucconi, Maria Gabriella
RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS
2017 Santoro, Cristina; Massaro, Fulvio; Baldacci, Erminia; Ferrara, G.; Malaspina, Francesco; Santoro, Rc; Pasca, S.; Castaman, G.; Peyvandi, F.; Foa, Roberto; Mazzucconi, Maria Gabriella
Rituximab in refractory idiopathic thrombocytopenic purpura (ITP)
2007 Santoro, Cristina; Biondo, F; De Propris, Ms; Guarini, A; Malandruccolo, L; Minotti, C; Rago, A; Foa, Roberto; Mazzucconi, Maria Gabriella
ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA
2015 Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Giuseppe, A; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, Giuliana; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella
ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA
2015 Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Avvisati, G; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Ferrara, G; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, G; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella
Sialylation regulates migration in chronic lymphocytic leukemia
2023 Natoni, Alessandro; Cerreto, Marina; De Propris, Maria Stefania; Del Giudice, Ilaria; Soscia, Roberta; Peragine, Nadia; Intoppa, Stefania; Milani, Maria Laura; Guarini, Anna; Foà, Robin
Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model
2020 Natoni, Alessandro; Farrell, Mariah L; Harris, Sophie; Falank, Carolyne; Kirkham-McCarthy, Lucy; Macauley, Matthew S; Reagan, Michaela R; O'Dwyer, Michael
SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS
2015 Andriani, A; Latagliata, R; Anaclerico, B; Spadea, A; Rago, A; Di Veroli, A; Spirito, F; Porrini, R; De Muro, M; Leonetti, Sc; Villiva, N; De Gregoris, C; Montefusco, E; Polverelli, N; Santoro, Cristina; Breccia, M; Cimino, Giuseppe; Majolino, I; Mazzucconi, Maria Gabriella; Vianelli, N; Alimena, G; Montanaro, M; Palandri, F.
La splenomegalia alla diagnosi di trombocitemia essenziale è un nuovo fattore di rischio trombotico?
2013 A., Andriani; R., Latagliata; M., Cedrone; A., Spadea; A., Rago; J., Di Giandomenico; F., Spirito; R., Porrini; M., De Muro; S., Crescenzi Leonetti; N., Villivà; C., De Gregoris; E., Montefusco; Santoro, Cristina; G., Cimino; I., Majolino; M. G., Mazzucconi; G., Alimena; M., Montanaro
Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14)
2020 Swan, Dawn; Delaney, Caoimhe; Natoni, Alessandro; O'Dwyer, Michael; Krawczyk, Janusz
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pharmacokinetics of the reformulated B-DOMAIN deleted recombinant factor VIII (BDD-RFVIII) concentrate using chromogenic and one-stage assays with pooled normal plasma (PNP) and refacto laboratory standard (RLS) | 2007 | Santoro, Cristina; Mazzucconi, Maria Gabriella; Pignoloni, F.; Rago, A.; Biondo, F.; Iorio, A.; Ferrante, F.; Agnelli, G.; Foa, R. | |
| Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study | 2024 | Kaiser, Francesca; Lunghi, Monia; Cardinali, Deborah; Bellomarino, Vittorio; Beldinanzi, Marco; Starza, Irene Della; Malfona, Francesco; Basilico, Claudia M.; Defina, Marzia; Mastaglio, Sara; Giglio, Fabio; Lazzarotto, Davide; Salutari, Prassede; Piccini, Matteo; Cardinali, Valeria; Pierini, Antonio; Fracchiolla, Nicola S.; Di Biase, Federica; Annunziata, Mario; Di Trani, Mariangela; Foa, Robin; Chiaretti, Sabina | |
| Preliminary data of a randomized pluricentric study (ABVD +RT EF versus IF) in intermediate stage Hodgkin’s disease (HD) | 1998 | Anselmo, Anna Paola; MAURIZI ENRICI, Riccardo; S., Proia; E., Cavalieri; B., Campanella; M., Cantonetti; G., Bellesi; G. P., Biti; Mandelli, Franco | |
| PREOPERATIVE USE OF THROMBOPOIETIN RECEPTOR AGONISTS IN ITP PATIENTS PRIOR TO SPLENECTOMY OR CARDIOVASCULAR SURGERY | 2014 | Rossi, E; Ciminello, A; Cedrone, M; Santoro, Cristina; Buccisano, F; De Padua, L; Za, T; Betti, S; Anaclerico, B; Mazzucconi, Maria Gabriella; De Stefano, V. | |
| PREVALENCE AND DETERMINANTS OF BLEEDING IN SEVERE VON WILLEBRAND DISEASE TYPE 3: RESULTS OF RETRO/PROSPECTIVE STUDIES IN A COHORT OF 105/52 ITALIAN PATIENTS | 2010 | Federici, A; Iorio, A.; Castaman, G.; Mazzucconi, Maria Gabriella; Morfini, M.; Rocino, A.; Schiavoni, M.; Mannucci, P. | |
| PRIOR THROMBOSIS AND CLINICO-BIOLOGICAL CHARACTERISTICS AT DIAGNOSIS IN THE PATIENTS OF THE THROMBOCYTHEMIAS ITALIAN REGISTRY: IS OLDER AGE A PRIMARY OR A SURROGATE PROTHROMBOTIC FACTOR? | 2014 | Gugliotta, L; Iurlo, A; Tieghi, A; Gugliotta, G; Candoni, A; Ricco, A; Lunghi, M; Rumi, E; Scalzulli, Pr; Dragani, A; Antonioli, E; Martinelli, V; Randi, Ml; Maschio, N; Appolloni, V; Cantore, N; Palmieri, F; Santoro, Cristina; Polverelli, N; De Biasi, E; Rago, A; Cacciola, R; Villa, Mr; Codeluppi, K; Piccin, A; Pierri, I; Martino, B; Santoro, U; Monari, P; Miglio, R. | |
| Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myelogenous leukemia. | 2004 | Ricciardi, Maria Rosaria; Mcqueen, T; Chism, Dd; Milella, M; Kaldjian, E; Sebolt Leopold, J; Konopleva, M; Andreeff, M. | |
| Reduction of glycosylated hemoglobin with stable insulin levels in a diabetic patient with chronic myeloid leukemia responsive to imatinib. | 2005 | M., Breccia; Muscaritoli, Maurizio; Alimena, Giuliana | |
| REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL | 2017 | Martini, V; Molfetta, R; Severin, F; Trimarco, V; Frezzato, F; Raggi, F; Martinello, L; Visentin, A; Scomazzon, E; Facco, M; Semenzato, G; Paolini, R; Trentin, L. | |
| Response of prostate cancer during imatinib therapy in a patient with chronic myeloid leukemia. | 2004 | Breccia, M.; De Cuia, M. R.; D'Elia, G. M.; Biondo, F.; Mandelli, Franco; Alimena, Giuliana | |
| RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF A-HYPO-FIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS | 2017 | Santoro, Cristina; Massaro, Fulvio; Baldacci, E; Ferrara, G; Ferretti, Antonietta; Santoro, Rc; Pasca, S; Castaman, G; Peyvandi, F; Foa, Roberto; Mazzucconi, Maria Gabriella | |
| RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS | 2017 | Santoro, Cristina; Massaro, Fulvio; Baldacci, Erminia; Ferrara, G.; Malaspina, Francesco; Santoro, Rc; Pasca, S.; Castaman, G.; Peyvandi, F.; Foa, Roberto; Mazzucconi, Maria Gabriella | |
| Rituximab in refractory idiopathic thrombocytopenic purpura (ITP) | 2007 | Santoro, Cristina; Biondo, F; De Propris, Ms; Guarini, A; Malandruccolo, L; Minotti, C; Rago, A; Foa, Roberto; Mazzucconi, Maria Gabriella | |
| ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA | 2015 | Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Giuseppe, A; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, Giuliana; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella | |
| ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA | 2015 | Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Avvisati, G; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Ferrara, G; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, G; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella | |
| Sialylation regulates migration in chronic lymphocytic leukemia | 2023 | Natoni, Alessandro; Cerreto, Marina; De Propris, Maria Stefania; Del Giudice, Ilaria; Soscia, Roberta; Peragine, Nadia; Intoppa, Stefania; Milani, Maria Laura; Guarini, Anna; Foà, Robin | |
| Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model | 2020 | Natoni, Alessandro; Farrell, Mariah L; Harris, Sophie; Falank, Carolyne; Kirkham-McCarthy, Lucy; Macauley, Matthew S; Reagan, Michaela R; O'Dwyer, Michael | |
| SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS | 2015 | Andriani, A; Latagliata, R; Anaclerico, B; Spadea, A; Rago, A; Di Veroli, A; Spirito, F; Porrini, R; De Muro, M; Leonetti, Sc; Villiva, N; De Gregoris, C; Montefusco, E; Polverelli, N; Santoro, Cristina; Breccia, M; Cimino, Giuseppe; Majolino, I; Mazzucconi, Maria Gabriella; Vianelli, N; Alimena, G; Montanaro, M; Palandri, F. | |
| La splenomegalia alla diagnosi di trombocitemia essenziale è un nuovo fattore di rischio trombotico? | 2013 | A., Andriani; R., Latagliata; M., Cedrone; A., Spadea; A., Rago; J., Di Giandomenico; F., Spirito; R., Porrini; M., De Muro; S., Crescenzi Leonetti; N., Villivà; C., De Gregoris; E., Montefusco; Santoro, Cristina; G., Cimino; I., Majolino; M. G., Mazzucconi; G., Alimena; M., Montanaro | |
| Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14) | 2020 | Swan, Dawn; Delaney, Caoimhe; Natoni, Alessandro; O'Dwyer, Michael; Krawczyk, Janusz |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile